Outset Medical (OM) Share-based Compensation (2019 - 2026)
Outset Medical's (OM) quarterly Share-based Compensation came in at $3.5 million in Q1 2026, up 15.99% year-on-year from $3.0 million in Q1 2025, and down 15.01% on a QoQ basis from $4.1 million in Q4 2025.
Outset Medical (OM) Share-based Compensation (2019 - 2026) Analysis & Trends
Outset Medical (OM) has 8 years of Share-based Compensation data on file, last reported at $3.5 million in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 15.99% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $16.1 million, a 407.92% increase from a year earlier, with the FY2025 full-year figure at $15.6 million, changed N/A from the prior year.
- Share-based Compensation for Q1 2026 stood at $3.5 million, down from $4.1 million in the prior quarter.
- Over the last five years, Share-based Compensation for OM reached as high as $10.9 million in Q3 2023 and fell as low as -$24.4 million in Q4 2024.
- Historically, Share-based Compensation has averaged $5.0 million across 5 years, with a median of $7.4 million in 2022.
- Across the five-year window, Share-based Compensation surged 159.43% in 2022 and slumped 368.31% in 2024, its largest moves.
- Year by year, Share-based Compensation stood at $7.4 million in 2022, then gained by 23.73% to $9.1 million in 2023, then slumped by 368.31% to -$24.4 million in 2024, then soared by 116.64% to $4.1 million in 2025, then decreased by 15.01% to $3.5 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $3.5 million in Q1 2026, $4.1 million in Q4 2025, and $5.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | 35.12 Mn |
| 10 | Outset Medical | 78,360.84 | -286.57 Mn | 12.10 Mn | 3.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.45 Mn |
| Mar 31, 2026 | 3.45 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Sep 30, 2025 | 5.08 Mn |
| Sep 30, 2025 | 5.08 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Dec 31, 2024 | -24.41 Mn |
| Dec 31, 2024 | -24.41 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Jun 30, 2024 | 9.82 Mn |
| Jun 30, 2024 | 9.82 Mn |
| Mar 31, 2024 | 8.20 Mn |
| Mar 31, 2024 | 8.20 Mn |
| Dec 31, 2023 | 9.10 Mn |
| Dec 31, 2023 | 9.10 Mn |